Nephron Sterile Compounding Center LLC 2022-06-08 Health serious FDA
Health · FDA · Recall #FDA-D-0963-2022
Neostigmine Methylsulfate Injection, USP, 5 mg/5 mL (1 mg/mL), Preservative Free, 5 mL… Recall
Issued June 8, 2022 · Nephron Sterile Compounding Center LLC
In June 2022, Nephron Sterile Compounding Center LLC recalled the Neostigmine Methylsulfate Injection, USP, 5 mg/5 mL (1 mg/mL), Preservative Free, 5 mL…, a serious health recall reported by the FDA. Affected owners are eligible for a voluntary. Here is what the hazard is and exactly what to do about it.
Compiled by Maya Ellison, RecallCheckr
What this means for you
Lack of Assurance of Sterility
What you should do
- 1 Stop using Neostigmine Methylsulfate Injection, USP, 5 mg/5 mL (1 mg/mL), Preservative Free, 5 mL… right away.
- 2 Set it aside where it won't be used by mistake.
- 3 Contact Nephron Sterile Compounding Center LLC to arrange your voluntary. See the official notice below for contact details.
- 4 Keep the product until your remedy is fully processed. You may need it.
Official remedy (Voluntary):
Recall details
- Brand
- Nephron Sterile Compounding Center LLC
- Category
- Health
- Recall date
- June 8, 2022
- Units affected
- Not reported
- Sold at
- Nationwide in the USA
- Recall number
- FDA-D-0963-2022
- Made in
- United States
- Issuing agency
- FDA
In context
- Nephron Sterile Compounding Center LLC has 29 recalls in our database.
- We're tracking 3,576 Health recalls in our database.
- This is the 870th Health recall we've logged in 2022.